International Stem Cell Corporation
ISCO · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -3.2% | 14.9% | -13% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 55.8% | 62.1% | 53.4% | 59.5% |
| EBITDA | $0 | $0 | -$0 | $0 |
| % Margin | 4.8% | 9% | -7.5% | 4.3% |
| Net Income | $0 | $0 | -$0 | $0 |
| % Margin | 2.4% | 5.3% | -12% | 0.4% |
| EPS Diluted | 0.007 | 0.008 | -0.032 | 0.001 |
| % Growth | -16.7% | 126.3% | -2,385.7% | – |
| Operating Cash Flow | $0 | -$0 | $0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | $0 | -$0 |